BB1BLINKLAB LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 13 Aug 2026, 00:35 | Resignation and Appointment of Auditor | Other | — | 12018 | |
| 5 Aug 2026, 20:04 | Investor Webinar - Positive European ADHD Study Results | Presentations | — | 14014 | |
| 5 Aug 2026, 19:15 | European ADHD Study Delivers Positive Results | Company Update | MS | 09014, 11001 | |
| 5 Aug 2026, 02:55 | Letter to Shareholders & Proxy Form | Meetings & Governance | — | 08004, 08006, 16002 | |
| 5 Aug 2026, 02:54 | Notice of Annual General Meeting & Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 3 Aug 2026, 19:24 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 1 Aug 2026, 00:28 | Appendix 4G & Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 1 Aug 2026, 00:26 | 2026 Annual Report & Appendix 4E | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 27 July 2026, 19:58 | BlinkLab to Present at TechKnow Invest Roadshow | Company Administration | — | 12008 | |
| 27 July 2026, 19:08 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 15 July 2026, 02:22 | Change of Director's Interest Notice x4 | Director Interests | — | 02009 | |
| 14 July 2026, 19:25 | Company Update on Clinical Development Programs | Company Update | — | 11001 | |
| 14 July 2026, 01:03 | Section 708A Notice | Securities Administration | — | 06018 | |
| 14 July 2026, 00:54 | Notification regarding unquoted securities - BB1 | Other | — | 06021 | |
| 14 July 2026, 00:44 | Application for quotation of securities - BB1 | Other | — | 06020 | |
| 14 July 2026, 00:35 | Application for quotation of securities - BB1 | Other | — | 06020 | |
| 2 July 2026, 02:44 | Notification regarding unquoted securities - BB1 | Other | — | 06021 | |
| 26 June 2026, 19:22 | European ADHD Study Update | Company Update | — | 11001 | |
| 26 June 2026, 02:53 | Results of General Meeting | Meetings & Governance | — | 08003 | |
| 18 June 2026, 19:20 | BB1 Granted Foundational U.S. Patent | Company Update | — | 11001 | |
| 16 June 2026, 19:11 | BB1 Partners with ESPOCH on Large-Scale Multicenter Program | Company Update | — | 11001 | |
| 22 May 2026, 21:22 | Letter to Shareholders & Proxy Form | Meetings & Governance | — | 08004, 16002 | |
| 22 May 2026, 21:20 | Notice of General Meeting & Proxy Form | Meetings & Governance | — | 08004, 08007 | |
| 19 May 2026, 19:46 | Therapy Evaluation for Neurodevelopmental Conditions | Company Update | — | 11001 | |
| 14 May 2026, 19:33 | BB1 to present at Stocks in the Vines Investor Access Day | Company Administration | — | 12008 | |
| 30 Apr 2026, 18:39 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 23 Apr 2026, 19:46 | Section 708A Notice | Securities Administration | — | 06018 | |
| 23 Apr 2026, 19:41 | Application for quotation of securities - BB1 | Other | — | 06020 | |
| 17 Apr 2026, 19:23 | BlinkLab Invited to Present at Ignite Investment Summits | Presentations | — | 03026 | |
| 17 Apr 2026, 03:44 | Update - Proposed issue of securities - BB1 | Securities Administration | — | 06013 | |
| 16 Apr 2026, 19:28 | Proposed issue of securities - BB1 | Securities Administration | — | 06013 | |
| 16 Apr 2026, 19:27 | BlinkLab Secures A$17.5M to Launch Autism Diagnostic Aid | Capital Raising | MS | 06003, 09014 | |
| 14 Apr 2026, 19:00 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 7 Apr 2026, 22:22 | Application for quotation of securities - BB1 | Other | — | 06020 | |
| 26 Mar 2026, 21:51 | Notice of Release of Escrowed Securities | Securities Administration | — | 06009 | |
| 24 Mar 2026, 20:35 | Validation Program Commences-FDA 510(k) - First Participant | Company Update | MS | 11001 | |
| 23 Mar 2026, 20:48 | Morocco's Nationwide Government-Funded Autism Screening | Company Update | MS | 09014, 11001 | |
| 19 Mar 2026, 20:38 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 16 Mar 2026, 20:44 | Clinical Trial Network for Pivotal FDA Study Complete | Company Update | MS | 11001 | |
| 13 Mar 2026, 20:21 | BlinkLab Forms Partnership with SHANK2 Autism Foundation | Company Update | — | 11001 | |
| 25 Feb 2026, 20:41 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 13 Feb 2026, 20:12 | Notification regarding unquoted securities - BB1 | Other | — | 06021 | |
| 12 Feb 2026, 20:31 | BB1 Expands Pivotal FDA Trial Network to Nine Elite Sites | Company Update | — | 11001 | |
| 30 Jan 2026, 19:36 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 23 Jan 2026, 20:07 | BB1 Presents at Simons Foundation Autism Research Initiative | Company Update | — | 11001 | |
| 8 Jan 2026, 20:08 | BlinkLab Receives $822k R&D Tax Incentive Refund | Periodic Reports | — | 03014, 12008 | |
| 5 Jan 2026, 20:16 | High-Profile Journal Publication Validates BB1 Technology | Company Update | MS | 11001 | |
| 19 Dec 2025, 21:09 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 19 Dec 2025, 21:06 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 18 Dec 2025, 20:02 | Appointment of Managing Director and Board Changes | Company Administration | MS | 12001, 12019 |
1–50 of 81
1 / 2